Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.
Inflamm Bowel Dis
; 29(12): 1847-1853, 2023 Dec 05.
Article
in En
| MEDLINE
| ID: mdl-36808256
This study explores the question of how IBD therapeutic efficacy may vary among racial groups.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Tumor Necrosis Factor Inhibitors
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Inflamm Bowel Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2023
Document type:
Article
Affiliation country: